Drug data last refreshed 16h ago · AI intelligence enriched 3w ago
Technetium TC 99m TSC is a radiopharmaceutical diagnostic imaging agent approved in 1976 for nuclear medicine applications. It is administered via injection or oral route as a solution to visualize specific physiological processes. The exact indications are not specified in available data, but TC 99m products are typically used for tissue perfusion and organ-specific imaging.
Product approaching loss of exclusivity with moderate competitive pressure (30/100), indicating potential team consolidation and shift toward transition planning rather than growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on Technetium TC 99m TSC offers limited career growth given LOE approach and zero linked job openings. Roles are primarily maintenance-focused, managing an established diagnostic product with stable but declining market dynamics.
Worked on TECHNETIUM TC 99M TSC at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.